Home » NAFDAC Newsroom
NAFDAC Newsroom
The list below provides information gathered from press releases and other public notices of The Agency
Highlights
-
The Year 2025 – NAFDAC Director General’s Strategic Plan
-
Public Alert No. 052/2024 - Alert of Confirmed Cases of Two Counterfeit Batches of Avastin 400mg/16ml, Manufactured By Roche Diagnostics Public Gmbh, Mannheim, Germany
-
Public Alert No. 051/2024 -Alert on Confirmed Counterfeit PHESGO 600mg600mg/10ml With Batch Number C5290S20 Stated to be Manufactured by Roche S,P,A.
-
Public Alert No. 050/2024 -Alert on the Recall of Apo-Amitriptyline 10mg and 25mg Manufactured by Pharma Forte Singapore Pte Ltd.
-
NAFDAC Refutes Claims of Approving Herbal Tea Promoting Smoking
-
Suspected Substandard Deekins Amoxycillin 500mg Capsule
News
- Press Announcements
- Speeches
- Events
- Approvals
- Warning Letters
- Notes to Industries
- Recalls & Alerts
- Testimony
Profile & Photos
Quick Links
- Approval of NAFDAC Regulated Products
- Freedom of Information
Events
- NAFDAC Meetings Conferences & Workshops
- Campus Tours
- Sensitization
- Content Current as of January 22, 2024
More Actions
Was this helpful?
Yes
No
Thanks for your feedback!